Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M.
PMID: 26174753
Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. Epub 2015 Jul 14.

We performed a case-control association study in persistent ADHD considering eight candidate genes (DRD4, DAT1/SLC6A3, COMT, ADRA2A, CES1, CYP2D6, LPHN3, and OPRM1) and found additional evidence for the involvement of the Dup 120bp and VNTR 48bp functional variants within...

Cite
Sánchez-Mora C, Richarte V, Garcia-Martínez I, et al. Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015;168(6):480-491doi: 10.1002/ajmg.b.32340.
Sánchez-Mora, C., Richarte, V., Garcia-Martínez, I., Pagerols, M., Corrales, M., Bosch, R., Vidal, R., Viladevall, L., Casas, M., Cormand, B., Ramos-Quiroga, J. A., & Ribasés, M. (2015). Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 168(6), 480-491. https://doi.org/10.1002/ajmg.b.32340
Sánchez-Mora, Cristina, et al. "Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder." American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics vol. 168,6 (2015): 480-491. doi: https://doi.org/10.1002/ajmg.b.32340
Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M. Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. Epub 2015 Jul 14. PMID: 26174753.
Copy Download .nbib Format: NLM
Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study.

Frontiers in psychology

Vidal R, Vidal L, Ristol F, Domènec E, Segú M, Vico C, Gomez-Barros N, Ramos-Quiroga JA.
PMID: 32528389
Front Psychol. 2020 May 26;11:1080. doi: 10.3389/fpsyg.2020.01080. eCollection 2020.

OBJECTIVE: The rationale of this study was to evaluate the efficacy of dog-assisted therapy (DAT) combined with pharmacological treatment in children and adolescents with fetal alcohol spectrum disorder (FASD).METHOD: We conducted a randomized, rater-blinded, controlled pilot trial in a...

Cite
Vidal R, Vidal L, Ristol F, et al. Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study. Front Psychol. 2020;11:1080doi: 10.3389/fpsyg.2020.01080.
Vidal, R., Vidal, L., Ristol, F., Domènec, E., Segú, M., Vico, C., Gomez-Barros, N., & Ramos-Quiroga, J. A. (2020). Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study. Frontiers in psychology, 111080. https://doi.org/10.3389/fpsyg.2020.01080
Vidal, Raquel, et al. "Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study." Frontiers in psychology vol. 11 (2020): 1080. doi: https://doi.org/10.3389/fpsyg.2020.01080
Vidal R, Vidal L, Ristol F, Domènec E, Segú M, Vico C, Gomez-Barros N, Ramos-Quiroga JA. Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study. Front Psychol. 2020 May 26;11:1080. doi: 10.3389/fpsyg.2020.01080. eCollection 2020. PMID: 32528389; PMCID: PMC7264372.
Copy Download .nbib Format: NLM
New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Alemany S, Ribasés M, Vilor-Tejedor N, Bustamante M, Sánchez-Mora C, Bosch R, Richarte V, Cormand B, Casas M, Ramos-Quiroga JA, Sunyer J.
PMID: 26174813
Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):459-470. doi: 10.1002/ajmg.b.32341. Epub 2015 Jul 14.

Attention deficit is one of the core symptoms of the attention-deficit/hyperactivity disorder (ADHD). However, the specific genetic variants that may be associated with attention function in adult ADHD remain largely unknown. The present study aimed to identifying SNPs associated...

Cite
Alemany S, Ribasés M, Vilor-Tejedor N, et al. New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015;168(6):459-470doi: 10.1002/ajmg.b.32341.
Alemany, S., Ribasés, M., Vilor-Tejedor, N., Bustamante, M., Sánchez-Mora, C., Bosch, R., Richarte, V., Cormand, B., Casas, M., Ramos-Quiroga, J. A., & Sunyer, J. (2015). New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 168(6), 459-470. https://doi.org/10.1002/ajmg.b.32341
Alemany, Silvia, et al. "New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder." American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics vol. 168,6 (2015): 459-470. doi: https://doi.org/10.1002/ajmg.b.32341
Alemany S, Ribasés M, Vilor-Tejedor N, Bustamante M, Sánchez-Mora C, Bosch R, Richarte V, Cormand B, Casas M, Ramos-Quiroga JA, Sunyer J. New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):459-470. doi: 10.1002/ajmg.b.32341. Epub 2015 Jul 14. PMID: 26174813.
Copy Download .nbib Format: NLM
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure.

Human brain mapping

Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, Bellgrove MA, Brandeis D, Brem S, Busatto GF, Calderoni S, Calvo R, Castellanos FX, Coghill D, Conzelmann A, Daly E, Deruelle C, Dinstein I, Durston S, Ecker C, Ehrlich S, Epstein JN, Fair DA, Fitzgerald J, Freitag CM, Frodl T, Gallagher L, Grevet EH, Haavik J, Hoekstra PJ, Janssen J, Karkashadze G, King JA, Konrad K, Kuntsi J, Lazaro L, Lerch JP, Lesch KP, Louza MR, Luna B, Mattos P, McGrath J, Muratori F, Murphy C, Nigg JT, Oberwelland-Weiss E, O'Gorman Tuura RL, O'Hearn K, Oosterlaan J, Parellada M, Pauli P, Plessen KJ, Ramos-Quiroga JA, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Shaw P, Silk TJ, Tamm L, Vilarroya O, Walitza S, Jahanshad N, Faraone SV, Francks C, van den Heuvel OA, Paus T, Thompson PM, Buitelaar JK, Franke B.
PMID: 32420680
Hum Brain Mapp. 2022 Jan;43(1):37-55. doi: 10.1002/hbm.25029. Epub 2020 May 18.

Neuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders...

Cite
Hoogman M, van Rooij D, Klein M, et al. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Hum Brain Mapp. 2020;43(1):37-55doi: 10.1002/hbm.25029.
Hoogman, M., van Rooij, D., Klein, M., Boedhoe, P., Ilioska, I., Li, T., Patel, Y., Postema, M. C., Zhang-James, Y., Anagnostou, E., Arango, C., Auzias, G., Banaschewski, T., Bau, C. H. D., Behrmann, M., Bellgrove, M. A., Brandeis, D., Brem, S., Busatto, G. F., Calderoni, S., Calvo, R., Castellanos, F. X., Coghill, D., Conzelmann, A., Daly, E., Deruelle, C., Dinstein, I., Durston, S., Ecker, C., Ehrlich, S., Epstein, J. N., Fair, D. A., Fitzgerald, J., Freitag, C. M., Frodl, T., Gallagher, L., Grevet, E. H., Haavik, J., Hoekstra, P. J., Janssen, J., Karkashadze, G., King, J. A., Konrad, K., Kuntsi, J., Lazaro, L., Lerch, J. P., Lesch, K. P., Louza, M. R., Luna, B., Mattos, P., McGrath, J., Muratori, F., Murphy, C., Nigg, J. T., Oberwelland-Weiss, E., O'Gorman Tuura, R. L., O'Hearn, K., Oosterlaan, J., Parellada, M., Pauli, P., Plessen, K. J., Ramos-Quiroga, J. A., Reif, A., Reneman, L., Retico, A., Rosa, P. G. P., Rubia, K., Shaw, P., Silk, T. J., Tamm, L., Vilarroya, O., Walitza, S., Jahanshad, N., Faraone, S. V., Francks, C., van den Heuvel, O. A., Paus, T., Thompson, P. M., Buitelaar, J. K., & Franke, B. (2022). Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Human brain mapping, 43(1), 37-55. https://doi.org/10.1002/hbm.25029
Hoogman, Martine, et al. "Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure." Human brain mapping vol. 43,1 (2022): 37-55. doi: https://doi.org/10.1002/hbm.25029
Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, Bellgrove MA, Brandeis D, Brem S, Busatto GF, Calderoni S, Calvo R, Castellanos FX, Coghill D, Conzelmann A, Daly E, Deruelle C, Dinstein I, Durston S, Ecker C, Ehrlich S, Epstein JN, Fair DA, Fitzgerald J, Freitag CM, Frodl T, Gallagher L, Grevet EH, Haavik J, Hoekstra PJ, Janssen J, Karkashadze G, King JA, Konrad K, Kuntsi J, Lazaro L, Lerch JP, Lesch KP, Louza MR, Luna B, Mattos P, McGrath J, Muratori F, Murphy C, Nigg JT, Oberwelland-Weiss E, O'Gorman Tuura RL, O'Hearn K, Oosterlaan J, Parellada M, Pauli P, Plessen KJ, Ramos-Quiroga JA, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Shaw P, Silk TJ, Tamm L, Vilarroya O, Walitza S, Jahanshad N, Faraone SV, Francks C, van den Heuvel OA, Paus T, Thompson PM, Buitelaar JK, Franke B. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Hum Brain Mapp. 2022 Jan;43(1):37-55. doi: 10.1002/hbm.25029. Epub 2020 May 18. PMID: 32420680.
Copy Download .nbib Format: NLM
The impact of insomnia disorder on adult attention-deficit/hyperactivity disorder severity: A six-month follow-up study.

Psychiatry research

Fadeuilhe C, Daigre C, Grau-López L, Richarte V, Palma-Álvarez RF, Corrales M, Sáez B, Baz M, Ramos-Quiroga JA.
PMID: 34998087
Psychiatry Res. 2021 Dec 20;308:114349. doi: 10.1016/j.psychres.2021.114349. Epub 2021 Dec 20.

BACKGROUND AND OBJECTIVES: The longitudinal relationship between insomnia disorder and adult attention-deficit/hyperactivity disorder (ADHD) has been scarcely investigated. This study aimed to evaluate the relationship between the remission of insomnia disorder and adult ADHD clinical severity, psychiatric and medical...

Cite
Fadeuilhe C, Daigre C, Grau-López L, et al. The impact of insomnia disorder on adult attention-deficit/hyperactivity disorder severity: A six-month follow-up study. Psychiatry Res. 2021;308:114349doi: 10.1016/j.psychres.2021.114349.
Fadeuilhe, C., Daigre, C., Grau-López, L., Richarte, V., Palma-Álvarez, R. F., Corrales, M., Sáez, B., Baz, M., & Ramos-Quiroga, J. A. (2021). The impact of insomnia disorder on adult attention-deficit/hyperactivity disorder severity: A six-month follow-up study. Psychiatry research, 308114349. https://doi.org/10.1016/j.psychres.2021.114349
Fadeuilhe, C, et al. "The impact of insomnia disorder on adult attention-deficit/hyperactivity disorder severity: A six-month follow-up study." Psychiatry research vol. 308 (2021): 114349. doi: https://doi.org/10.1016/j.psychres.2021.114349
Fadeuilhe C, Daigre C, Grau-López L, Richarte V, Palma-Álvarez RF, Corrales M, Sáez B, Baz M, Ramos-Quiroga JA. The impact of insomnia disorder on adult attention-deficit/hyperactivity disorder severity: A six-month follow-up study. Psychiatry Res. 2021 Dec 20;308:114349. doi: 10.1016/j.psychres.2021.114349. Epub 2021 Dec 20. PMID: 34998087.
Copy Download .nbib Format: NLM
Electrophysiological Brain Changes Associated With Cognitive Improvement in a Pediatric Attention Deficit Hyperactivity Disorder Digital Artificial Intelligence-Driven Intervention: Randomized Controlled Trial.

Journal of medical Internet research

Medina R, Bouhaben J, de Ramón I, Cuesta P, Antón-Toro L, Pacios J, Quintero J, Ramos-Quiroga JA, Maestú F.
PMID: 34842533
J Med Internet Res. 2021 Nov 26;23(11):e25466. doi: 10.2196/25466.

BACKGROUND: Cognitive stimulation therapy appears to show promising results in the rehabilitation of impaired cognitive processes in attention deficit hyperactivity disorder.OBJECTIVE: Encouraged by this evidence and the ever-increasing use of technology and artificial intelligence for therapeutic purposes, we examined...

Cite
Medina R, Bouhaben J, de Ramón I, et al. Electrophysiological Brain Changes Associated With Cognitive Improvement in a Pediatric Attention Deficit Hyperactivity Disorder Digital Artificial Intelligence-Driven Intervention: Randomized Controlled Trial. J Med Internet Res. 2021;23(11):e25466doi: 10.2196/25466.
Medina, R., Bouhaben, J., de Ramón, I., Cuesta, P., Antón-Toro, L., Pacios, J., Quintero, J., Ramos-Quiroga, J. A., & Maestú, F. (2021). Electrophysiological Brain Changes Associated With Cognitive Improvement in a Pediatric Attention Deficit Hyperactivity Disorder Digital Artificial Intelligence-Driven Intervention: Randomized Controlled Trial. Journal of medical Internet research, 23(11), e25466. https://doi.org/10.2196/25466
Medina, Rafael, et al. "Electrophysiological Brain Changes Associated With Cognitive Improvement in a Pediatric Attention Deficit Hyperactivity Disorder Digital Artificial Intelligence-Driven Intervention: Randomized Controlled Trial." Journal of medical Internet research vol. 23,11 (2021): e25466. doi: https://doi.org/10.2196/25466
Medina R, Bouhaben J, de Ramón I, Cuesta P, Antón-Toro L, Pacios J, Quintero J, Ramos-Quiroga JA, Maestú F. Electrophysiological Brain Changes Associated With Cognitive Improvement in a Pediatric Attention Deficit Hyperactivity Disorder Digital Artificial Intelligence-Driven Intervention: Randomized Controlled Trial. J Med Internet Res. 2021 Nov 26;23(11):e25466. doi: 10.2196/25466. PMID: 34842533.
Copy Download .nbib Format: NLM
End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital.

Frontiers in psychiatry

Beneria A, Castell-Panisello E, Sorribes-Puertas M, Forner-Puntonet M, Serrat L, García-González S, Garriga M, Simon C, Raya C, Montes MJ, Rios G, Bosch R, Citoler B, Closa H, Corrales M, Daigre C, Delgado M, Dip ME, Estelrich N, Jacas C, Lara B, Lugo-Marin J, Nieto-Fernández Z, Regales C, Ibáñez P, Blanco E, Ramos-Quiroga JA.
PMID: 34040548
Front Psychiatry. 2021 May 03;12:608973. doi: 10.3389/fpsyt.2021.608973. eCollection 2021.

No abstract available.

Cite
Beneria A, Castell-Panisello E, Sorribes-Puertas M, et al. End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital. Front Psychiatry. 2021;12:608973doi: 10.3389/fpsyt.2021.608973.
Beneria, A., Castell-Panisello, E., Sorribes-Puertas, M., Forner-Puntonet, M., Serrat, L., García-González, S., Garriga, M., Simon, C., Raya, C., Montes, M. J., Rios, G., Bosch, R., Citoler, B., Closa, H., Corrales, M., Daigre, C., Delgado, M., Dip, M. E., Estelrich, N., Jacas, C., Lara, B., Lugo-Marin, J., Nieto-Fernández, Z., Regales, C., Ibáñez, P., Blanco, E., & Ramos-Quiroga, J. A. (2021). End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital. Frontiers in psychiatry, 12608973. https://doi.org/10.3389/fpsyt.2021.608973
Beneria, Anna, et al. "End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital." Frontiers in psychiatry vol. 12 (2021): 608973. doi: https://doi.org/10.3389/fpsyt.2021.608973
Beneria A, Castell-Panisello E, Sorribes-Puertas M, Forner-Puntonet M, Serrat L, García-González S, Garriga M, Simon C, Raya C, Montes MJ, Rios G, Bosch R, Citoler B, Closa H, Corrales M, Daigre C, Delgado M, Dip ME, Estelrich N, Jacas C, Lara B, Lugo-Marin J, Nieto-Fernández Z, Regales C, Ibáñez P, Blanco E, Ramos-Quiroga JA. End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital. Front Psychiatry. 2021 May 03;12:608973. doi: 10.3389/fpsyt.2021.608973. eCollection 2021. PMID: 34040548; PMCID: PMC8143029.
Copy Download .nbib Format: NLM
Integrating genomics and transcriptomics: Towards deciphering ADHD.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Pujol-Gualdo N, Sánchez-Mora C, Ramos-Quiroga JA, Ribasés M, Soler Artigas M.
PMID: 33495110
Eur Neuropsychopharmacol. 2021 Mar;44:1-13. doi: 10.1016/j.euroneuro.2021.01.002. Epub 2021 Jan 23.

Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable condition that represents the most common neurodevelopmental disorder in childhood, persisting into adulthood in around 40-65% of the cases. ADHD is characterised by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity. Mounting evidence...

Cite
Pujol-Gualdo N, Sánchez-Mora C, Ramos-Quiroga JA, et al. Integrating genomics and transcriptomics: Towards deciphering ADHD. Eur Neuropsychopharmacol. 2021;44:1-13doi: 10.1016/j.euroneuro.2021.01.002.
Pujol-Gualdo, N., Sánchez-Mora, C., Ramos-Quiroga, J. A., Ribasés, M., & Soler Artigas, M. (2021). Integrating genomics and transcriptomics: Towards deciphering ADHD. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 441-13. https://doi.org/10.1016/j.euroneuro.2021.01.002
Pujol-Gualdo, Natàlia, et al. "Integrating genomics and transcriptomics: Towards deciphering ADHD." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 44 (2021): 1-13. doi: https://doi.org/10.1016/j.euroneuro.2021.01.002
Pujol-Gualdo N, Sánchez-Mora C, Ramos-Quiroga JA, Ribasés M, Soler Artigas M. Integrating genomics and transcriptomics: Towards deciphering ADHD. Eur Neuropsychopharmacol. 2021 Mar;44:1-13. doi: 10.1016/j.euroneuro.2021.01.002. Epub 2021 Jan 23. PMID: 33495110.
Copy Download .nbib Format: NLM
Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates.

Psychological medicine

Bosch R, Pagerols M, Rivas C, Sixto L, Bricollé L, Español-Martín G, Prat R, Ramos-Quiroga JA, Casas M.
PMID: 33436129
Psychol Med. 2021 Jan 13;1-11. doi: 10.1017/S0033291720005115. Epub 2021 Jan 13.

BACKGROUND: Prevalence estimates of neurodevelopmental disorders (ND) are essential for treatment planning. However, epidemiological research has yielded highly variable rates across countries, including Spain. This study examined the prevalence and sociodemographic correlates of ND in a school sample of...

Cite
Bosch R, Pagerols M, Rivas C, et al. Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates. Psychol Med. 2021;1-11doi: 10.1017/S0033291720005115.
Bosch, R., Pagerols, M., Rivas, C., Sixto, L., Bricollé, L., Español-Martín, G., Prat, R., Ramos-Quiroga, J. A., & Casas, M. (2021). Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates. Psychological medicine, 1-11. https://doi.org/10.1017/S0033291720005115
Bosch, Rosa, et al. "Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates." Psychological medicine vol. (2021): 1-11. doi: https://doi.org/10.1017/S0033291720005115
Bosch R, Pagerols M, Rivas C, Sixto L, Bricollé L, Español-Martín G, Prat R, Ramos-Quiroga JA, Casas M. Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates. Psychol Med. 2021 Jan 13;1-11. doi: 10.1017/S0033291720005115. Epub 2021 Jan 13. PMID: 33436129.
Copy Download .nbib Format: NLM
Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability.

Nature neuroscience

Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BML, Ong JS, Ip HF, van der Zee MD, Bartels M, Day FR, Fontanillas P, Elson SL, de Wit H, Davis LK, MacKillop J, Derringer JL, Branje SJT, Hartman CA, Heath AC, van Lier PAC, Madden PAF, Mägi R, Meeus W, Montgomery GW, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Paus T, Ribases M, Kaprio J, Boks MPM, Bell JT, Spector TD, Gelernter J, Boomsma DI, Martin NG, MacGregor S, Perry JRB, Palmer AA, Posthuma D, Munafò MR, Gillespie NA, Derks EM, Vink JM.
PMID: 31168101
Nat Neurosci. 2019 Jul;22(7):1196. doi: 10.1038/s41593-019-0402-7.

Several occurrences of the word 'schizophrenia' have been re-worded as 'liability to schizophrenia' or 'schizophrenia risk', including in the title, which should have been "GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and...

Cite
Pasman JA, Verweij KJH, Gerring Z, et al. Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nat Neurosci. 2019;22(7):1196doi: 10.1038/s41593-019-0402-7.
Pasman, J. A., Verweij, K. J. H., Gerring, Z., Stringer, S., Sanchez-Roige, S., Treur, J. L., Abdellaoui, A., Nivard, M. G., Baselmans, B. M. L., Ong, J. S., Ip, H. F., van der Zee, M. D., Bartels, M., Day, F. R., Fontanillas, P., Elson, S. L., de Wit, H., Davis, L. K., MacKillop, J., Derringer, J. L., Branje, S. J. T., Hartman, C. A., Heath, A. C., van Lier, P. A. C., Madden, P. A. F., Mägi, R., Meeus, W., Montgomery, G. W., Oldehinkel, A. J., Pausova, Z., Ramos-Quiroga, J. A., Paus, T., Ribases, M., Kaprio, J., Boks, M. P. M., Bell, J. T., Spector, T. D., Gelernter, J., Boomsma, D. I., Martin, N. G., MacGregor, S., Perry, J. R. B., Palmer, A. A., Posthuma, D., Munafò, M. R., Gillespie, N. A., Derks, E. M., & Vink, J. M. (2019). Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nature neuroscience, 22(7), 1196. https://doi.org/10.1038/s41593-019-0402-7
Pasman, Joëlle A, et al. "Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability." Nature neuroscience vol. 22,7 (2019): 1196. doi: https://doi.org/10.1038/s41593-019-0402-7
Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BML, Ong JS, Ip HF, van der Zee MD, Bartels M, Day FR, Fontanillas P, Elson SL, de Wit H, Davis LK, MacKillop J, Derringer JL, Branje SJT, Hartman CA, Heath AC, van Lier PAC, Madden PAF, Mägi R, Meeus W, Montgomery GW, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Paus T, Ribases M, Kaprio J, Boks MPM, Bell JT, Spector TD, Gelernter J, Boomsma DI, Martin NG, MacGregor S, Perry JRB, Palmer AA, Posthuma D, Munafò MR, Gillespie NA, Derks EM, Vink JM. Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nat Neurosci. 2019 Jul;22(7):1196. doi: 10.1038/s41593-019-0402-7. PMID: 31168101.
Copy Download .nbib Format: NLM
Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates.

Frontiers in psychiatry

Fadeuilhe C, Daigre C, Richarte V, Grau-López L, Palma-Álvarez RF, Corrales M, Ramos-Quiroga JA.
PMID: 34122179
Front Psychiatry. 2021 May 26;12:663889. doi: 10.3389/fpsyt.2021.663889. eCollection 2021.

No abstract available.

Cite
Fadeuilhe C, Daigre C, Richarte V, et al. Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates. Front Psychiatry. 2021;12:663889doi: 10.3389/fpsyt.2021.663889.
Fadeuilhe, C., Daigre, C., Richarte, V., Grau-López, L., Palma-Álvarez, R. F., Corrales, M., & Ramos-Quiroga, J. A. (2021). Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates. Frontiers in psychiatry, 12663889. https://doi.org/10.3389/fpsyt.2021.663889
Fadeuilhe, Christian, et al. "Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates." Frontiers in psychiatry vol. 12 (2021): 663889. doi: https://doi.org/10.3389/fpsyt.2021.663889
Fadeuilhe C, Daigre C, Richarte V, Grau-López L, Palma-Álvarez RF, Corrales M, Ramos-Quiroga JA. Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates. Front Psychiatry. 2021 May 26;12:663889. doi: 10.3389/fpsyt.2021.663889. eCollection 2021. PMID: 34122179; PMCID: PMC8187558.
Copy Download .nbib Format: NLM
Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus.

Revista de psiquiatria y salud mental

Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, Dom G, Faraone SV, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Matthys F, Moggi F, Møller M, Schellekens A, Skutle A, van de Glind G, van Emmerik-van Oortmerssen K, Verspreet S, Schoevers RA, Wallhed S, Levin FR, Grau-López L, Casas M, van den Brink W, Ramos-Quiroga JA.
PMID: 32561156
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Jun 16; doi: 10.1016/j.rpsm.2020.04.013. Epub 2020 Jun 16.

OBJECTIVE: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.METHOD:...

Cite
Palma-Álvarez RF, Barta C, Carpentier PJ, et al. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Rev Psiquiatr Salud Ment (Engl Ed). 2020;doi: 10.1016/j.rpsm.2020.04.013.
Palma-Álvarez, R. F., Barta, C., Carpentier, P. J., Carruthers, S., Crunelle, C. L., Demetrovics, Z., Dom, G., Faraone, S. V., Franck, J., Johnson, B., Kapitány-Fövény, M., Kaye, S., Konstenius, M., Matthys, F., Moggi, F., Møller, M., Schellekens, A., Skutle, A., van de Glind, G., van Emmerik-van Oortmerssen, K., Verspreet, S., Schoevers, R. A., Wallhed, S., Levin, F. R., Grau-López, L., Casas, M., van den Brink, W., Ramos-Quiroga, J. A. (2020). Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Revista de psiquiatria y salud mental, . https://doi.org/10.1016/j.rpsm.2020.04.013
Palma-Álvarez, Raul Felipe, et al. "Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus." Revista de psiquiatria y salud mental vol. (2020). doi: https://doi.org/10.1016/j.rpsm.2020.04.013
Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, Dom G, Faraone SV, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Matthys F, Moggi F, Møller M, Schellekens A, Skutle A, van de Glind G, van Emmerik-van Oortmerssen K, Verspreet S, Schoevers RA, Wallhed S, Levin FR, Grau-López L, Casas M, van den Brink W, Ramos-Quiroga JA. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Rev Psiquiatr Salud Ment (Engl Ed). 2020 Jun 16; doi: 10.1016/j.rpsm.2020.04.013. Epub 2020 Jun 16. Spanish. PMID: 32561156.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries